Brind.
  1. IceCure Medical is expanding its ProSense technology adoption in Europe while seeking FDA authorization for a breast cancer treatment and planning North American commercialization.

IceCure Medical began marketing its technologies in India, alongside markets in Israel, the US, and Japan.

2 reports, 2 independent Updated Aug 8
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

IceCure Medical began marketing its technologies in India, alongside markets in Israel, the US, and Japan.

Who's involved

What this event is mainly about
IceCure MedicalIndia

How it developed

Newest first. Tap a step to see who reported it.
  1. IceCure Medical expands its market reach by entering India.1 source
  2. IceCure Medical expands its market presence into Europe and Asia.1 source

Keep exploring

Part of

IceCure Medical is expanding its ProSense technology adoption in Europe while seeking FDA authorization for a breast cancer treatment and planning North American commercialization. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • Simply Wall St.When Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit? IceCure Medical Ltd (NASDAQ:ICCM) is possibly approaching a major achievement in its business, so we would like to shine some light on the c
  • PR NewswireIceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 CAESAREA, Israel, Aug. 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" o